Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Imatinib as a novel therapeutic approach for fibrotic disorders.

Literature DB >> 19029132

Imatinib as a novel therapeutic approach for fibrotic disorders.

J H W Distler, O Distler.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2008 PMID： 19029132 DOI： 10.1093/rheumatology/ken431

Source DB: PubMed Journal: Rheumatology (Oxford) ISSN： 1462-0324 Impact factor: 7.580

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

Review 1. Evidence-based management of rapidly progressing systemic sclerosis.

Authors: Dinesh Khanna; Christopher P Denton
Journal: Best Pract Res Clin Rheumatol Date: 2010-06 Impact factor: 4.098

2. SSc in 2011: From mechanisms to medicines.

Authors: Luc Mouthon
Journal: Nat Rev Rheumatol Date: 2012-01-10 Impact factor: 20.543

3. Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design.

Authors: Dinesh Khanna; James R Seibold; Athol Wells; Oliver Distler; Yannick Allanore; Chris Denton; Daniel E Furst
Journal: Curr Rheumatol Rev Date: 2010-05-01

4. Platelet-derived growth factor receptor-α is essential for cardiac fibroblast survival.

Authors: Malina J Ivey; Jill T Kuwabara; Kara L Riggsbee; Michelle D Tallquist
Journal: Am J Physiol Heart Circ Physiol Date: 2019-05-24 Impact factor: 4.733

5. A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung disease.

Authors: Dinesh Khanna; Rajeev Saggar; Maureen D Mayes; Fereidoun Abtin; Philip J Clements; Paul Maranian; Shervin Assassi; Rajan Saggar; Ram R Singh; Daniel E Furst
Journal: Arthritis Rheum Date: 2011-11

6. Imatinib mesylate causes genome-wide transcriptional changes in systemic sclerosis fibroblasts in vitro.

Authors: Monique Hinchcliff; Chiang-Ching Huang; Wataru Ishida; Feng Fang; Jungwha Lee; Nadareh Jafari; Mark Wilkes; Swati Bhattacharyya; Edward Leof; John Varga
Journal: Clin Exp Rheumatol Date: 2012-05-29 Impact factor: 4.473

Review 7. Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trials.

Authors: Karen Au; Dinesh Khanna; Philip J Clements; Daniel E Furst; Donald P Tashkin
Journal: Curr Rheumatol Rep Date: 2009-04 Impact factor: 4.592